Clinical Trial Update: Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing vinblastine plus prednisone versus cytarabine alone for Langerhans cell histiocytosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• CYTARABINE (CYTARABINE)
• PREDNISONE (Prednisone)
• Vinblastine (vinblastine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Langerhans Cell Histiocytosis | Phase 3 | Status: RECRUITING